Related Experiment Videos
[Coronary heart disease and osteoporosis: factors related to development of both diseases]
Grazyna Nowicka1, Bogumiła Panczenko-Kresowska
1Pracownia Metaboliczna, Zaklad Profilaktyki Chorób Zywieniowozaleznych, Instytut Zywności i Zywienia, Warszawa. gnowicka@izz.waw.pl
Insights
Coronary heart disease and osteoporosis, once thought unrelated, share common risk factors. Emerging evidence reveals a pathological link, with treatments for one potentially benefiting the other.
Area of Science:
- Cardiovascular Science
- Bone Metabolism
- Geriatric Medicine
Context:
- Coronary heart disease (CHD) and osteoporosis are prevalent in aging populations.
- Traditionally viewed as distinct, a pathological link is increasingly recognized.
- Shared risk factors include hyperlipidemia, hypertension, diabetes, oxidative stress, inflammation, and hyperhomocysteinemia.
Purpose:
- To explore the pathological link between coronary heart disease and osteoporosis.
- To investigate shared etiological factors contributing to both conditions.
- To examine the reciprocal effects of treatments for CHD and osteoporosis.
Summary:
- CHD and osteoporosis share common risk factors such as hyperlipidemia, hypertension, and inflammation.
- Statins, used for hyperlipidemia, also stimulate bone formation.
- Bisphosphonates, an osteoporosis treatment, can lower cholesterol and inhibit atherosclerotic plaque.
Impact:
- Highlights the interconnectedness of cardiovascular and bone health in aging.
- Suggests potential for combined therapeutic strategies targeting shared pathways.
- Informs clinical practice regarding the management of patients with co-existing CHD and osteoporosis.
Abstract:
Coronary heart disease and osteoporosis are common diseases in aging populations. Traditionally, these diseases have been considered as distinct and unrelated. However, nowadays there has been increasing evidence indicating a pathological link between these two disorders. Both diseases share etiological factors as hyperlipidemia, hypertension, diabetes, oxidative stress, inflammation, hyperhomocysteinemia. Statins, hypolipidemic drugs, not only reduce atherogenesis but also stimulate bone formation. Bisphosphonates, drugs used in osteoporosis treatment, have been shown to influence serum cholesterol levels and inhibit atherosclerotic plaque formation.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Coronary Artery Disease II: Pathophysiology